Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease

[1]  Zhongqiu Lin,et al.  Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer , 2016, PloS one.

[2]  E. Hwang,et al.  Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus , 2016, Journal of Korean medical science.

[3]  P. Pozzilli,et al.  Hot topics on diabetes in China , 2015, Diabetes/metabolism research and reviews.

[4]  Tingting Xu.  Chinese Anti-Cancer Association as a non-governmental organization undertakes systematic cancer prevention work in China. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[5]  Z. Dong,et al.  Cancer Prevention Research in China , 2015, Cancer Prevention Research.

[6]  A. Lissoni,et al.  Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival , 2015, International Journal of Gynecologic Cancer.

[7]  S. Byun,et al.  Preoperative Glycemic Control Status as a Significant Predictor of Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy , 2015, PloS one.

[8]  Kathleen R. Cho,et al.  Cervical cancer, version 2.2015: Featured updates to the NCCN guidelines featured updates to the NCCN guidelines , 2015 .

[9]  T. Sugiyama,et al.  Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy , 2015, International Journal of Clinical Oncology.

[10]  Chao-yuan Huang,et al.  Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma , 2015, Diabetes/metabolism research and reviews.

[11]  P. Scherer,et al.  Hyperglycemia as a Risk Factor for Cancer Progression , 2014, Diabetes & metabolism journal.

[12]  V. Baladandayuthapani,et al.  The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma , 2014, British Journal of Cancer.

[13]  Jun Wang,et al.  Challenges to effective cancer control in China, India, and Russia. , 2014, The Lancet. Oncology.

[14]  Hong‐Lin Chen,et al.  Responsiveness of neoadjuvant chemotherapy before surgery predicts favorable prognosis for cervical cancer patients: a meta-analysis , 2013, Journal of Cancer Research and Clinical Oncology.

[15]  Wanqing Chen,et al.  The incidence and mortality of major cancers in China, 2012 , 2013, Chinese journal of cancer.

[16]  Q. Cai,et al.  Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type , 2010, Advances in hematology.

[17]  S. Kubo,et al.  The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus‐related hepatocellular carcinoma , 2012, Journal of surgical oncology.

[18]  R. Dunn,et al.  Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes. , 2012, The Journal of urology.

[19]  R. Jiménez-García,et al.  Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010. , 2012, Diabetes & metabolism.

[20]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[21]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[22]  Jeong-Won Lee,et al.  Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA). , 2010, Gynecologic oncology.

[23]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[24]  M. Haymond,et al.  Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. , 2009, The Journal of pediatrics.

[25]  S. Spechler,et al.  Elevated HbA1c Is an Independent Predictor of Aggressive Clinical Behavior in Patients with Colorectal Cancer: A Case-Control Study , 2008, Digestive Diseases and Sciences.

[26]  G. Thomas,et al.  Is there a role for pelvic lymph node debulking in advanced cervical cancer? , 2002, Gynecologic oncology.

[27]  C. Ko,et al.  The need for a multidisciplinary approach to cancer care. , 2002, The Journal of surgical research.

[28]  R. Boronow.  The bulky 6-cm barrel-shaped lesion of the cervix: primary surgery and postoperative chemoradiation. , 2000, Gynecologic oncology.

[29]  A. Belfiore,et al.  Insulin receptors in breast cancer: Biological and clinical role , 1996, Journal of endocrinological investigation.

[30]  A. Costantino,et al.  Insulin Receptors in Breast Cancer , 1996, Annals of the New York Academy of Sciences.

[31]  C. Desch,et al.  The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. , 1996, Archives of internal medicine.

[32]  N. Hacker,et al.  Resection of bulky positive lymph nodes in patients with cervical carcinoma , 1994, International Journal of Gynecologic Cancer.

[33]  H. Peterse,et al.  Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer , 1991, Breast Cancer Research and Treatment.

[34]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[35]  R Kevin Reynolds,et al.  Cervical Cancer, Version 2.2015. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[36]  C. Rock,et al.  Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  L. Kennedy,et al.  Utility of A1C for Diabetes Screening in the 1999-2004 NHANES Population , 2008 .